Foundation capital

The Galien Foundation Announces the 2022 Prix Galien USA Nominees for “Best Digital Health Solution”, “Incubators, Accelerators and Equity” and “Prix Galien Startup”

— In partnership with Business France, the Trophies will be awarded on October 27, 2022at the Galien Prize UNITED STATES Award Ceremony at New York City

NEW YORK, July 28, 2022 /PRNewswire/ — The Galien Foundation, the world’s premier institution dedicated to honoring innovators in the life sciences, today announced the 2022 Prix Galien UNITED STATES Nominated for “Best digital health solution”, “Incubators, accelerators and equity” and “Prix Galien Startup” awards. The winners will be announced during the Prix Galien UNITED STATES Award Ceremony on October 27, 2022at the American Museum of Natural History in New York City.

“The Prix Galien Awards have become the most coveted prizes for those who dedicate their lives to the development of meaningful medicines and innovations,” said Bernard Poussot, Director, Roche Holding, Former Chairman and CEO, Wyeth, Prix Galien Startup, Digital Health and Incubators, Accelerators and Equity Committee Chairman. “Awards committee members applaud each nominee’s unwavering commitment to their quest to provide a healthier future for the next generation.”

The brand new Prix Galien category, “Incubators, Accelerators and Equity”, recognizes the role played by these institutions in guiding the next wave of innovators by offering a range of mentoring skills, including expertise in designing clinical trials, legal advice, laboratory space, professional development. , peer-to-peer support, free access to leading advisors, and economic support to advance innovation in the life sciences.

“During my 30-year career at Johnson & Johnson, I’ve learned the importance of casting a wide net in the pursuit of new ideas while taking on the task of turning them into meaningful products for patients,” said Alex Gorsky, Executive Chairman, Johnson & Johnson, member of the Prix Galien Startup, Digital Health and Incubators, Accelerators and Equity Committee. “It is an honor to join the Awards jurors responsible for recognizing innovative industry best practices in the new Award category.”

Judges will evaluate submissions using seven criteria, including details on how the incubator/accelerator meets the needs of accepted applicants, information on how success is measured during the incubation period, acceleration or financing, and examples of companies that have “graduated” or “exited” from the incubator and/or accelerator, along with the candidate’s 800-word profile.

“At Alexandria, we are extremely proud to play a vital role in driving life science entrepreneurship and innovation, as well as growing life science ecosystems, through our first-of-its-kind, best-in-class life science startup platform Alexandria LaunchLabs®. We organize and merge mission-critical real estate, seed-stage venture capital, mentorship, and business-building resources to accelerate the translation of scientific discoveries into new treatments and cures to help meet significant unmet medical needs. satisfied with the company,” said Joel S.Marcus, JD, CPA, Executive Chairman and Founder, Alexandria Real Estate Equities, Inc./Alexandria Venture Investments. “I am honored to join the prestigious jury of the Prix Galien, and with the creation of this new category of awards, the Fondation Galien is once again positioning itself at the forefront of efforts that will help advance medicines to improve , prolonging and saving the lives of patients around the world.”

The “Best Digital Health Solution” category recognizes excellence in research and development that has significantly improved the human condition. The “Prix Galien Startup” category, which rewards and supports innovation around the world, will announce three winners for “Best Startup in the Pharmaceutical or Biotechnology Industry”, “Best Startup in the Medical Technology Industry” and “Best Startup of digital health”. Industry.” Frederic RossiManaging Director Business France for North America emphasizes the “tremendous opportunity for French companies to present amazing projects and meet American health leaders for the rapid adoption of essential innovations”.

Incubators, accelerators and equity (nominated)

AIM-HI Accelerator Fund

AION Laboratories

aMoon Fund

BioLabs/LabCentral

Consuli, Inc.: Bargain

Design technologies: ELabNYC | ABCT | WCBA | Next step

Dynamic Capital

FUTURE4CARE Accelerator

Innovation Johnson & Johnson – JLABS

Kittyhawk Ventures

Lead Sports & Health Tech Partners: LakeNona Academy

MATTER Startup Incubation

mHUBMedTech Accelerator

The Novartis Biome

Scripps Research

VIB

Villgro Africa

Walgreens Clinical Trials

Best Digital Health Solution (nominees)

Helping Health, Inc

MouthLab Vital Signs Monitoring System

here.ai

red dot® V2 clinical analysis software

Great Health

Day light

BioSensics

Home Biodigit

Butterfly Network Inc

Butterfly iQ+

Digital Diagnostics Inc.

IDx-DR

exscientia

Exscientia’s AI-powered end-to-end precision medicine platform

Flow.is

Flow: Meditation for Modern Life

medable

Medable Decentralized Clinical Trials Platform

Novadiscovery

JINKO

Patientory Inc.

patient room

Therapixel

MammoScreen®

Viz.ai

Contact

Galien Startup Prize (nominees)

Aqemia

Pharma/Biotech

Aurion Biotech

Pharma/Biotech

BrenusPharma

Pharma/Biotech

CTIBIOTECH

Pharma/Biotech

Therapeutic Curia

Pharma/Biotech

Deka Biosciences

Pharma/Biotech

diaccurate

Pharma/Biotech

Genoscience

Pharma/Biotech

Hummingbird Bioscience

Pharma/Biotech

MAIA Biotechnology

Pharma/Biotech

Therapeutics of the Parthenon

Pharma/Biotech

Therapeutic ReCode

Pharma/Biotech

Smart Immunity

Pharma/Biotech

Acorai

medical technology

Drawingtey

medical technology

Dynocardia

medical technology

Epilab

medical technology

I.Ceram

medical technology

imaginostic

medical technology

Quantum surgery

medical technology

Remedy Labs

medical technology

Beauty

medical technology

Standard bariatrics

medical technology

Veloce Corp (SmartTab)

medical technology

Abys Medical

Digital health

Akili Interactive

Digital health

Blockcube

Digital health

Cardiac signal

Digital health

fifth eye

Digital health

Medexprim

Digital health

MindMics

Digital health

OccamzRazor

Digital health

Pentavere

Digital health

SeqOneGenomics

Digital health

Synvision

Digital health

We are fighting

Digital health

Prix ​​Galien Startup, Digital Health and Incubators, Accelerators and Equity Committee 2022

Bernard Poussot
Director, Roche Holding, former Chairman and CEO, Wyeth
President

Roch DOLIVEUX
Honorary CEO, UCB

Mikael DOLSTEN
Global President R&D, Pfizer

Jean-Pierre GARNIER
Former CEO, GSK

Alex GORSKY
Executive Chairman, Johnson & Johnson

Penny KITTEN
Global Therapeutic Area Manager, Vaccines, Janssen

Sheri McCoy
Board of Directors, AstraZeneca, former CEO, Have

François MAISONROUGE
Senior Managing Director, Evercore Partners

Joel S. MARCUS
Executive Chairman and Founder, Alexandria

Elias ZERHOUNI
Former Head of Global R&D, Sanofi

Prix ​​Galien Incubators, Accelerators and Actions Category Subcommittee 2022

Gil BACHE
Managing Partner, Chair Global Health, Finn Partners
Chairman of the sub-committee jury

Ron COHEN, MD
Founder, President and CEO, Acordia Therapeutics

Jamey Edwards
Former CEO, Emergent Medical Associates

Amir KALALI, MD
Chair and Chief Curator, CNS Summit/Co-Chair, Decentralized Trial Research Alliance

Michelle LONGMIRE, MD
Co-founder and CEO, Medable Inc.

Cheryl PEGUS, MD
Executive Vice President of Health and Wellness, Walmart

James PRUTOW, JD, MBA
Advisory Partner – Life Sciences, Molecular Diagnostics, Global Healthcare, PwC Consulting

About the Galien Foundation

The Fondation Galien encourages, recognizes and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatments and technologies that will impact the state of medical practice and save lives.

The Foundation oversees and directs activities in the United States for the Prix Galien, an international awards program dedicated to progress through the development of innovative medicines, with chapters in 14 countries and Africa. The Prix Galien was created in 1970 by Roland Mehl in honor of Galen, the father of modern medical science and pharmacology. Worldwide, the Prix Galien is considered the equivalent of the Nobel Prize for biopharmaceutical research.

About Enterprise France

Company France is the national support agency for the international development of the French economy, responsible for promoting the development of exports by French companies, as well as promoting and facilitating international investment in France. He favors France companies, corporate image and national attractiveness as a location for investment, and also runs the VIE international internship programme. For more information, visit: www.businessfrance.fr – @businessfrance

For more information, visit www.galienfoundation.org.

Follow the Foundation on social networks:
https://www.facebook.com/FondationGalien/
https://twitter.com/GalienFdn
https://www.linkedin.com/company/the-galien-foundation/

Media Contact:
Kara Bradley
Finnish partners
[email protected]
646-213-7243

SOURCE The Galen Foundation